The Molecular Genetics of Wilms Tumor

References

• Breslow N E, Beckwith J B. Epidemiological features of Wilms' tumor: Results of the National Wilms' Tumor Study. J Natl Cancer Inst 1982; 68: 429–436
   PubMed Web of Science ®Google Scholar
• Breslow N, Beckwith J B, Ciol M, Sharples K. Age distribution of Wilms' tumor: Report from the National Wilms' Tumor Study. Cancer Res 1988; 48: 1653–1657
   PubMed Web of Science ®Google Scholar
• Green D M, D'Angio G J, Beckwith J B, . Wilms' tumor (nephroblastoma, renal embryoma). Principles and Practice in Pediatric Oncology, P A Pizzo, D G Poplack, et al. JB Lippincott, Philadelphia 1993; 713–737
   Google Scholar
• Breslow N E, Langholtz B. Childhood cancer incidence: Geographical and temporal variations. Int J Cancer 1983; 32: 703–716
   PubMed Web of Science ®Google Scholar
• Coppes M J, De Kraker J, Van Dijken P J, et al. Bilateral Wilms' tumor: Long-term survival and some epidemiological features. J Clin Oncol 1989; 7: 310–315
   PubMed Web of Science ®Google Scholar
• Tournade M F, Com-Nougué C, Voûte P A, et al. Results of the sixth International Society of Pediatric Oncology Wilms' tumor trial and study: A risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol 1993; 11: 1014–1023
   PubMed Web of Science ®Google Scholar
• D'Angio G J, Breslow N, Beckwith J B, et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 1989; 64: 349–360
   PubMed Web of Science ®Google Scholar
• Beckwith J B. Wilms' tumor and other renal tumors of childhood. Pathology of Neoplasia in Children and Adolescents, M Finegold. WB Saunders, Philadelphia 1986; 313–332
   Google Scholar
• Beckwith J B, Kiviat N B, Bonadio J F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990; 10: 1–36
   PubMedGoogle Scholar
• Yeger H, Cullinane C, Flenniken A, et al. Coordinate expression of Wilms tumor genes correlates with Wilms tumor phenotypes. Cell Growth Different 1992; 3: 855–864
   PubMedGoogle Scholar
• Knudson A G, Strong L C. Mutation and cancer: A model for Wilms' tumor of kidney. J Natl Cancer Inst 1972; 48: 313–324
   PubMed Web of Science ®Google Scholar
• Knudson A G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Comings D E. A general theory of carcinogenesis. Proc Natl Acad Sci USA 1973; 70: 3324–3328
   PubMed Web of Science ®Google Scholar
• Bonaiti-Pellié C, Chompret A, Tournade M F, et al. Genetics and epidemiology of Wilms' tumor: The French Wilms' Tumor Study. Med Pediatr Oncol 1992; 20: 284–291
   PubMedGoogle Scholar
• Matsanuga E. Genetics of Wilms' tumor. Hum Genet 1981; 57: 231–246
   PubMed Web of Science ®Google Scholar
• Friend S H, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–646
   PubMed Web of Science ®Google Scholar
• Lee W H, Bookstein R, Hong F, et al. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 1987; 253: 1394–1399
   Google Scholar
• Gallie B, Squire J, Goddard A, et al. Mechanism of oncogenesis in retinoblastoma. Lab Invest 1990; 62: 394–408
   PubMed Web of Science ®Google Scholar
• Riccardi V M, Sujansky E, Smith A C, et al. Chromosomal imbalance in the aniridia—Wilms' tumor association: IIp interstitial deletion. Pediatrics 1978; 61: 604–610
   PubMed Web of Science ®Google Scholar
• Koufos A, Hansen M F, Lampkin B C, et al. Loss of alleles at loci on human chromosome II during genesis of Wilm's tumour. Nature 1984; 309: 170–172
   PubMed Web of Science ®Google Scholar
• Orkin S H, Goldman D S, Sallen S E. Development of homozygosity for chromosome IIp markers in Wilms' tumour. Nature 1984; 309: 172–174
   PubMed Web of Science ®Google Scholar
• Reeve A E, Housiaux P J, Gardner R JM, et al. Loss of a Harvey ras allele in sporadic Wilms' tumour. Nature 1984; 309: 174–176
   PubMed Web of Science ®Google Scholar
• Fearon E R, Vogelstein B, Feinberg A P. Somatic deletion and duplication of genes on chromosome II in Wilms' tumours. Nature 1984; 309: 176–178
   PubMed Web of Science ®Google Scholar
• Lewis W H, Yeger H, Bonetta L, et al. Homozygous deletion of a DNA marker from chromosome IIp13 in sporadic Wilms tumor. Genomics 1988; 3: 25–31
   PubMedGoogle Scholar
• Call K M, Glaser T, Ito C Y, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome II Wilms' tumor locus. Cell 1990; 60: 509–520
   PubMed Web of Science ®Google Scholar
• Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774–778
   PubMed Web of Science ®Google Scholar
• Bonetta L, Kuehn S E, Huang A, et al. Wilms tumor locus on IIp13 defined by multiple CpG island-associated transcripts. Science 1990; 250: 994–997
   PubMed Web of Science ®Google Scholar
• Haber D A, Sohn R L, Buckler A J, et al. Alternative splicing and genomic structure of the Wilms tumor gene WTI. Proc Natl Acad Sci USA 1991; 88: 9618–9622
   PubMed Web of Science ®Google Scholar
• Rauscher F J, III, Morris J E, Tournay O E, et al. Binding of the Wilms' tumor locus zinc finger protein to the EGRI consensus sequence. Science 1990; 250: 1259–1262
   PubMed Web of Science ®Google Scholar
• Huang A, Campbell C E, Bonetta L, et al. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science 1990; 250: 991–994
   PubMed Web of Science ®Google Scholar
• Ton C C, Huff V, Call K M, et al. Smallest reqion of overlap in Wilms tumor deletions uniquely implicates an IIp13 zinc finger gene as the disease locus. Genomics 1991; 10: 293–297
   PubMed Web of Science ®Google Scholar
• Davis L M, Zabel B, Senger G, et al. A tumor chromosome re-arrangement further defines the IIp13 Wilms tumor locus. Genomics 1991; 10: 588–592
   PubMed Web of Science ®Google Scholar
• Royer-Pokora B, Ragg S, Heckl O B, et al. Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in IIp13 are rare. Genes Chromosomes Cancer 1991; 3: 89–100
   PubMed Web of Science ®Google Scholar
• Cowell J K, Wadey R B, Haber D A, et al. Structural rearrangements of the WTI gene in Wilms' tumour cells. Oncogene 1991; 6: 595–599
   PubMed Web of Science ®Google Scholar
• Pelletier J, Bruening W, Li F P, et al. WTI mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 1991; 353: 431–434
   PubMed Web of Science ®Google Scholar
• Huff V, Miwa H, Haber D A, et al. Evidence for WTI as a Wilms' tumor (WT) gene: Intragenic germinal deletion in bilateral WT. Am J Hum Genet 1991; 8: 997–1003
   Google Scholar
• Little M H, Prosser J, Condie A, et al. Zinc finger point mutations within the WTI gene in Wilms tumor patients. Proc Natl Acad Sci USA 1992; 89: 4791–4795
   PubMed Web of Science ®Google Scholar
• Coppes M J, Liefers G J, Paul P, et al. Homozygous somatic WTI point mutations in sporadic unilateral Wilms tumor. Proc Natl Acad Sci USA 1993; 90: 1416–1419
   PubMed Web of Science ®Google Scholar
• Coppes M J, Bonetta L, Huang A, et al. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for non-disjunction or mitotic re-combination. Genes Chromosomes Cancer 1992; 5: 326–334
   PubMed Web of Science ®Google Scholar
• Pritchard-Jones K, Fleming S, Davidson D, et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990; 346: 194–197
   PubMed Web of Science ®Google Scholar
• Van Heyningen V, Bickmore W A, Seawright A, et al. Role for the Wilms tumor gene in genital development?. Proc Natl Acad Sci USA 1990; 87: 5383–5386
   PubMed Web of Science ®Google Scholar
• Pelletier J, Bruening W, Kashtan C E, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437–447
   PubMed Web of Science ®Google Scholar
• Bruening W, Bardeesy N, Silverman B L, et al. Germline intronic and exonic mutations in the Wilms' tumor gene (WTI) affecting urogenital development. Nature Genet 1992; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Coppes M J, Higuchi M, Liefers G J, et al. Inherrited WTI mutations in Denys-Drash syndrome. Cancer Res 1992; 52: 6125–6128
   PubMed Web of Science ®Google Scholar
• Denys P, Malvaux P, Van Den Bergh H, et al. Association d'un syndrôme anatomopathologique de pseudohermaphroditism masculin, d'une tumeur de Wilms, d'une néphropathie parenchymateuse et d'un mosaïcism XX/YY. Arch Franç Pédiatr 1967; 24: 729–739
   PubMedGoogle Scholar
• Drash A, Sherman F, Hartmann W, et al. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1970; 76: 585–593
   PubMed Web of Science ®Google Scholar
• Jadresic L, Leake J, Gordon I, et al. Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J Pediatr 1990; 117: 717–725
   PubMed Web of Science ®Google Scholar
• Baird P N, Santos A, Groves N, et al. Constitutional mutations in the WTI gene in patients with Denys-Drash. Hum Mol Genet 1991; 1: 301–305
   Google Scholar
• Herkowitz I. Functional inactivation of genes by dominant negative mutations. Nature 1987; 329: 219–222
   PubMed Web of Science ®Google Scholar
• Levine A J, Momand J, Finlay C A. The p53 tumour suppressor gene. Nature 1991; 351: 453–456
   PubMed Web of Science ®Google Scholar
• Bernards R, Schackleford F, Gerber M, et al. Structure and expression of the murine retinoblastoma gene and characterization of its encoding protein. Proc Natl Acad Sci USA 1989; 86: 6474–6478
   PubMed Web of Science ®Google Scholar
• Buckler A J, Pelletier J, Haber D A, et al. Isolation, characterization, and expresion of the murine Wilms' tumor gene (WTI) during kidney develoment. Mol Cell Biol 1991; II: 1707–1712
   Google Scholar
• Haber D A, Buckler A J, Glaser T, et al. An internal deletion within an IIp13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990; 61: 1257–1269
   PubMed Web of Science ®Google Scholar
• Miwa H, Tomlinson G E, Timmons C F, et al. RNA expression of the WTI gene in Wilms' tumors in relation to histology. J Natl Cancer Inst 1992; 84: 181–187
   PubMed Web of Science ®Google Scholar
• Gerald W L, Gramling T S, Sens D A, et al. Expression of the IIp13 Wilms' tumor gene, WTI, correlates with histologic category of Wilms' tumor. Am J Pathol 1992; 140: 1031–1037
   PubMed Web of Science ®Google Scholar
• Mannens M, Slater R M, Heyting C, et al. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome II in Wilms' tumours. Hum Genet 1988; 81: 41–48
   PubMed Web of Science ®Google Scholar
• Reeve A E, Sih S A, Raizis A M, et al. Loss of allelic heterozygosity at a second locus on chromosome II in sporadic Wilms' tumor cells. Mol Cell Biol 1989; 9: 1799–1803
   PubMed Web of Science ®Google Scholar
• Mannens M, Devilee P, Bliek J, et al. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome II. Cancer Res 1990; 50: 3279–3283
   PubMed Web of Science ®Google Scholar
• Henry I, Grandjouan S, Couillin P, et al. Tumor-specific loss of IIp15.5 alleles in dell Ip13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 1989; 86: 3247–3251
   PubMed Web of Science ®Google Scholar
• Wadey R B, Pal N, Buckle B, et al. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome II. Oncogene 1990; 5: 901–907
   PubMed Web of Science ®Google Scholar
• Junien C. Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr Opin Genet Dev 1992; 2: 431–438
   PubMed Web of Science ®Google Scholar
• Koufos A, Grundy P, Morgan K, et al. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to IIp15.5. Am J Hum Genet 1989; 44: 711–719
   PubMed Web of Science ®Google Scholar
• Ping A J, Reeve A E, Law D J, et al. Genetic linkage of Beckwith-Wiedemann syndrome to IIp15. Am J Hum Genet 1989; 44: 720–723
   PubMed Web of Science ®Google Scholar
• Waziri M, Patil S, Hanson J, et al. Abnormality of a chromosome II in patients with features of Beckwith-Wiedemann syndrome. J Pediatr 1983; 102: 873–876
   PubMed Web of Science ®Google Scholar
• Turleau C, De Grouchy J, Chavin-Colin F, et al. Trisomy IIp15 and Beckwith-Wiedemann syndrome: A report of two cases. Hum Genet 1984; 67: 219–221
   PubMed Web of Science ®Google Scholar
• Journel A, Lucas I, Allaire C, et al. Trisomy IIp15 and Beckwith-Wiedemann syndrome. Ann Genet 1985; 28: 97–101
   PubMedGoogle Scholar
• Okano Y, Osasa Y, Yamamoto H, et al. An infant with Beckwith-Wiedemann syndrome and chromosomal duplication IIp13-pter: Correlation of symptoms between IIp trisomy and Beckwith-Wiedemann syndrome. Jpn J Hum Genet 1986; 31: 365–372
   Google Scholar
• Wales J HK, Walker V, Moore I E, et al. Bronze baby syndrome, biliary hypoplasia, imcomplete Beckwith-Wiedemann syndrome and partial trisomy. Eur J Pediatr 1986; 145: 141–145
   PubMed Web of Science ®Google Scholar
• Henry I, Jeanpierre M, Couillin P, et al. Molecular definition of the IIp15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma. Hum Genet 1989; 81: 273–277
   PubMed Web of Science ®Google Scholar
• Brown K W, Williams J C, Maitland N J, et al. Genomic imprinting and the Beckwith-Wiedemann syndrome. Am J Hum Genet 1990; 46: 1000–10001
   PubMed Web of Science ®Google Scholar
• Tonoki H, Narahara N, Marsumoto J, et al. Regional mapping of the parathyroid hormone gene (PTH) by cytogenetic and molecular studies. Cytogenet Cell Genet 1991; 56: 103–104
   PubMedGoogle Scholar
• Henry I, Bonaïti-Pellie C, Chehensee V, et al. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 1991; 351: 665–667
   PubMed Web of Science ®Google Scholar
• Grundy P, Telzerow P, Paterson M C, et al. Chromosome II uniparental isodisomy predisposing to embryonal neoplasms. Lancet 1991; 338: 1079–1080, (letter)
   PubMed Web of Science ®Google Scholar
• Maw M A, Grundy P E, Millow L J, et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992; 52: 3094–3098
   PubMed Web of Science ®Google Scholar
• Tsuda H, Zhang W, Shimosato Y, et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6791–6794
   PubMed Web of Science ®Google Scholar
• Grundy P, Koufos A, Morgan K, et al. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome II. Nature 1988; 336: 374–376
   PubMed Web of Science ®Google Scholar
• Huff V, Compton D A, Chao L Y, et al. Lack of linkage of familial Wilms' tumour to chromosomal band IIp13. Nature 1988; 336: 377–378
   PubMed Web of Science ®Google Scholar
• Schwartz C E, Haber D A, Stanton V P, et al. Familial predisposition to Wilms tumor does not segregate with the WTI gene. Genomics 1991; 10: 927–930
   PubMed Web of Science ®Google Scholar
• Huff V, Reeve A E, Leppert M, et al. Nonlinkage of 16q markers to familial predisposition to Wilms tumor. Cancer Res 1992; 52: 6117–6120
   PubMed Web of Science ®Google Scholar
• Schroeder W T, Chao L-Y, Dao D D, et al. Nonrandom loss of maternal chromosome II alleles in Wilms tumors. Am J Hum Genet 1987; 40: 413–420
   PubMed Web of Science ®Google Scholar
• Jeanpierre C, Antignac C, Beroud C, et al. Constitutional and somatic deletions of two different regions of maternal chromosome II in Wilms tumor. Genomics 1990; 7: 434–438
   PubMed Web of Science ®Google Scholar
• Williams J C, Brown K W, Mott M G, et al. Maternal allele loss in Wilms' tumour. Lancet 1989; 1: 283–284, (letter)
   PubMed Web of Science ®Google Scholar
• Pal N, Wadey R B, Buckle B, et al. Preferential loss of maternal alleles in sporadic Wilms' tumour. Oncogene 1990; 5: 1665–1668
   PubMed Web of Science ®Google Scholar
• Surani M A, Barton S C, Norris M L. Experimental reconstruction of mouse eggs and embryos: an analysis of mammalian develoment. Biol Reprod 1987; 36: 1–16
   PubMed Web of Science ®Google Scholar
• Reik W. Genomic imprinting and embryonal tumours. Nature 1989; 338: 112–113
   PubMed Web of Science ®Google Scholar
• Shire J GM. Unequal parental contributions: genomic imprinting in mammals. New Biol 1989; 2: 115–120
   Google Scholar
• Hall J G. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet 1990; 46: 857–873
   PubMed Web of Science ®Google Scholar
• Wilkins R J. Genomic imprinting and carcinogenesis. Lancet 1988; 1: 329–331
   PubMed Web of Science ®Google Scholar
• Reik W. Genomic imprinting and genetic disorders in man. Hum Genet 1989; 5: 331–336
   Google Scholar
• Little M H, Dunn R, Byrne J A, et al. Equivalent expression of paternally and maternally inherited WTI allele in normal fetal tissue and Wilms' tumours. Oncogene 1992; 7: 635–741
   PubMed Web of Science ®Google Scholar
• Bartolomei M S, Zemel S, Tilghman S. Parental imprinting of the mouse H19 gene. Nature 1991; 351: 153–155
   PubMed Web of Science ®Google Scholar
• De Chiara T M, Robertson E J, Efstratiadias A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991; 64: 849–859
   PubMed Web of Science ®Google Scholar
• Mannens M. The molecular genetics of Wilms' tumour and associated congenital diseases. PhD thesis, Amsterdam, Rodopi 1991
   Google Scholar